Q3: Subsequent Cellular Infusions

*Combined follow up
In scenarios where an HCT was given after a cellular therapy and this form is now being completed based on the subsequent HCT date, this question does not apply and is disabled.

*Subsequent Cellular Infusions
All additional cellular therapy infusions of the same product given for the same indication per protocol require a separate Cellular Therapy Infusion (4006) form. However, they will only require a single Pre-CTED (4000) form and a single Cellular Therapy Product (4003) form for this course of cellular therapy. Any infusion part of a single course of cellular therapy is NOT reported here, even if it occurred in this reporting period.

If a cellular therapy was administered for a different indication (i.e., in response to disease progression / no response, another infusion of a commercial product, etc.) a new Pre-Cellular Therapy Essential Data (4000) form must be completed.

!Subsequent infusions for loss of B-cell aplasia
Subsequent infusions given for loss of B-cell aplasia are NOT reported here. The number of infusions reported on the Cellular Therapy Product (4003) Form should be updated and a new Cellular Therapy Infusion (4006) Form must be completed. A new Pre-CTED (4000) Form is not required for the subsequent infusion.

*Reporting subsequent infusions “on demand”
If a subsequent infusion (e.g. DLI, allo boost) was reported “on demand”, it also needs to be reported here. A new Form 2814 will come due. Submit a request via CIBMTR Center Support to have the form removed.

Question 3: Did the recipient receive a subsequent infusion?

Indicate if the recipient received a subsequent infusion during the reporting period. Subsequent infusions include transplant, cellular therapy, gene therapy, DLI, and ‘boost’ (autologous or allogeneic).

If Yes, complete the Indication for CIBMTR Data Reporting (2814) form.

For more information on infusion types, review Appendix D: How to Distinguish Infusion Types.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2025 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.